Abstract
The batch productivity (Q TM) of the production of the nucleoside antibiotic toyocamycin (TM) by Streptomyces chrestomyceticus was increased ten-fold by selection of a UV generated mutant, optimization of pH, increasing incubation temperature from 28 °C to 36 °C, and addition of soy oil. Initial high oxygen transfer rates stimulated Q TM maxima two-fold. Antibiotic production by the mutant strain, U190, however, appeared more shear sensitive than the parent culture FCRF 341 with maximum antibiotic titer being inversely related to impellor tip velocity, T v . For this reason, scale-up could not be done at constant P/V or constant volumetric oxygen transfer. Instead, programming of impeller speed was evaluated in order to maintain optimal impeller tip velocity during scale-up. It was found that a low constant T v maintained in scale-up in geometrically similar vessels was most beneficial for duplication of optimal antibiotic productivity, Q TM. Pilot fermentations (120 dm3 scale) were used to determine coefficients of Q TM variation from oxygen uptake rate (OUR) and total CO2 evolution data for monitoring of Q TM variation during scale-up to the 12,000 dm3 scale. This technique allowed for on-line prediction of antibiotic titer and Q TM from fermentor exhaust gas data.
Similar content being viewed by others
Abbreviations
- A :
-
scale constant
- B :
-
shape constant
- C :
-
location of maximum constant
- D m:
-
impeller diameter (m)
- H m:
-
liquid height (m)
- OTR MmolO2·(dm3)−1min−1 :
-
oxygen transfer rate
- OUR MmolO2·(dm3)−1min−1 :
-
oxygen uptake rate
- PCV cm3 :
-
packed cell volume
- P/V watts/dm3 :
-
volumetric power consumption
- Q 1 · min−1 corrected to standard conditions of temperature, pressure:
-
aeration rate
- Q TM μg/(cm3 · h) or kg/(m3 · h):
-
antibiotic productivity
- T m:
-
tank diameter
- T mix s:
-
mixing time
- T v cm · s−1 :
-
impeller tip velocity
- TM μg/cm3 :
-
Toyocamycin concentration
- TNP :
-
Tricyclic nucleoside phosphate
References
Kuenzi, M. T.: Process design and control in antibiotic fermentations. In: Hutter, R.; Leisinger, T.; Nuesch, J.; Wehrli, W. (Ed.): Antibiotics and Other Secondary Metabolites — Biosynthesis and Production, pp. 39–56. New York: Academic Press 1978
Bylinkira, E. S.; Bikukov, V. V.: The problem of scale-up in antibiotic biosynthesis. Proc. IV IFS: Ferment. Technol. Today (1972) 105–115
Young, T. B.; Koplove, H. M.: A systems approach to design and control of antibiotic fermentation. Proc. IV IFS: Ferment. Technol. Today (1972) 163–166
Oldshue, J. Y: How to keep “funny things from happening” when a fermenter is scaled up. Proceedings of the American Chemical Society's Annual Meeting. MBT Division, Sept. 1979
Banks, G. T.: Scale-up of fermentation processes. In: Wiseman, A. (Ed.): Topics in Enzyme and Fermentation Biotechnology, pp. 170–266. John Wiley and Sons 1979
Miura, Y: Transfer of oxygen and scale-up in submerged aerobic fermentation. Adv. Biochem. Eng. 4 (1976) 3–40
Jain, D.; Buckland, B. C.: Scale-up of the efrotomycin fermentation using a computer controlled pilot plant. Biopr. Eng. 3 (1988) 31–36
Hirose, Y.; Enei, H.; Shibai, H.: Nucleosides and nucleotides. In: Perlman, D. (Ed.): Annual reports on fermentation processes, vol. 3, pp. 253–274. Academic Press 1979
Nakao, Y.: Microbial production of nucleosides and nucleotides. In: Peppler, H. J.; Perlman, D. (Eds.): Microbial technology, vol. 1, pp. 312–354. Academic Press 1979
Schadolnik, R. J.; Uematsu, T.: Biosynthesis of the pyrrolopyrimidine nucleoside antibiotic toyocamycin VII. Origin of the pyrrole carbons and the cyano carbon. J. Biol. Chem. 245 (1970) 4365–4371
Nishimara, H.; Katagiri, K.; Sato, K.; Mayama, M.; Shimaoka, N.: Toyocamycin, a new anti-candida antibiotic S. J Antibiotics Sec. A9. 2 (1956) 60–62
Rao, K. V; Brook, P.; Marsh, W. S.; Renn, W.; Ren, D. W.: U.S. Patent 3, 116, 221. Dec. 31, 1963
Ohkurma, K.: Chemical structure of toyocamycin. J Antibiotics. 14 (1961) 343–352
Kominek, L. A.: Biosynthesis of novobiocin by Streptomyces niveus. Antimicrobial Agents Chemotherapy. 1 (1972) 123–134
Forrest, E. H.; Jansen, N. B.; Flickinger, M. C.; Tsao, G. T.: A simple hobby computer-based off gas analysis system. Biotechnol. Bioeng. 23 (1981) 455–460
Elstner, E. F.; Suhadolnik, R. J.: The biosynthesis of the nucleoside antibiotics IX. Purification and properties of guanosine triphosphate 8-formylhydrolase that catalyzes production of formic acid from the ureido carbon of guanosine triphosphate. J. Biol. Chem. 246 (1971) 6973–6981
Suhadolnik, R. J.; Uematsu, T.: Biosynthesis of pyrrolopyrimidine nucleoside antibiotic toyocamycin. J. Biol. Chem. 245 (1970) 4365–4371
Martin, J. F; Demain, A. L.: Control of antibiotic biosynthesis. Microbial Revs. 44 (1980) 230–251
Weinberg, D.: Regulation by phosphate and trace elements. Folia Microbiol. 23 (1978) 496–504
Martin, J. F; Naharro, G.; Liras, P.; Villanueva, J. R.: Isolation of mutants deregulated in phosphate control of candicidin biosynthesis. J. Antibiotics. 32 (1979) 600–606
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flickinger, M.C., Greenstein, M., Bremmon, C. et al. Strain selection, medium development and scale-up of toyocamycin production by streptomyces chrestomyceticus. Bioprocess Engineering 5, 143–153 (1990). https://doi.org/10.1007/BF00369578
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00369578